India's Central Drugs Standard Control Organization (CDSCO) flagged 37 batches of medicines for failing quality tests in November, reported livemint.com.

Specifically, a batch of MacLeod Pharmaceuticals' tuberculosis-treating drug Coxerin failed to meet the standards set for "condensation products and assay" tests.

A batch of Intas Pharmaceuticals' acid-reflux combination containing rabeprazole and domperidon failed to meet the criteria set for a dissolution test.

One batch each of Karnataka Antibiotics & Pharmaceuticals, Albro Pharmaceuticals and Elfin Drugs' albendazole also failed dissolution tests.

In addition, a batch of Bengal Chemicals & Pharmaceuticals' amlodipine has also failed the assay test, while one batch of its antibiotic metronidazole also couldn't pass the dissolution test.

Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the reproduced articles,
please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.